Annual report pursuant to Section 13 and 15(d)

QUARTERLY FINANCIAL DATA (UNAUDITED) - Revised Consolidated Statements of Equity (Details)

v3.23.1
QUARTERLY FINANCIAL DATA (UNAUDITED) - Revised Consolidated Statements of Equity (Details) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Beginning balance (in shares)             13,651,521                
Beginning balance $ 243,778,365 $ 262,833,595 $ 264,261,332 $ 263,631,523 $ 267,657,718 $ 250,882,083 $ 251,036,352 $ 149,399,827 $ 263,631,523 $ 149,399,827 $ 263,631,523 $ 149,399,827 $ 263,631,523 $ 149,399,827 $ 476,739,439
Net income (loss) (552,849) (15,501,704) 2,170,126 4,364,757 (188,675) 5,919,971 2,427,409 (10,694,263) 6,534,883 (8,266,854) (8,966,821) (2,346,883) (9,519,669) (2,535,558) (306,067,579)
Non-controlling interest 116,893,428 116,863,817 116,816,116 116,816,116 116,816,116 116,816,116 116,611,762 115,323,036 116,816,116 116,611,762 116,863,817 116,816,116 116,893,428 116,816,116  
Series A preferred stock dividends   (2,388,130) (2,388,130) (2,388,130)   (2,388,130) (2,309,672) (2,309,672)     (7,164,390)   (9,552,519) (9,395,604) (9,242,797)
Non-controlling interest income allocation (809,212) (809,212) (809,212) (809,212) (809,212) (1,046,304) (1,010,951) 0 (1,618,424) (1,010,951) (2,427,636) (2,057,255) (3,236,848) (2,866,467) 0
Common Stock dividends   (753,043) (748,031) (744,659)     (682,576) (682,576)     (2,245,733)        
Equity attributable to non-controlling interest           204,353 1,288,726 115,323,036           116,816,115  
Common Stock dividends           (741,530) (682,576) $ (682,576) (1,492,690)       (3,004,579) (2,850,026) (12,286,368)
Reinvestment of dividends paid to common stockholders   197,980 196,151 207,053   174,619 132,795   403,204   601,184   803,923 410,580  
Common stock issued under director's compensation plan           22,500               22,500  
Common Stock, accrued dividend equivalent   (34,145)                 (34,145)   (67,431)    
Crimson cash distribution on A-1 Units   (809,212) (809,212) (809,212)   (841,950) (604,951)   (1,618,424)   (2,427,636)   (3,236,848) (2,256,113)  
Crimson Class A-2 Units dividends payment in kind           (204,353) (406,000)     (406,000)   (610,353) 0 (610,353) 0
Stock-based compensation   233,024 151,359           151,359   384,383   612,117    
Ending balance (in shares)               13,651,521              
Ending balance $ 239,666,517 $ 243,778,365 $ 262,833,595 $ 264,261,332 $ 263,631,523 267,657,718 $ 250,882,083 $ 251,036,352 262,833,595 $ 250,882,083 $ 243,778,365 267,657,718 239,666,517 263,631,523 149,399,827
Series A, Internalization                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Series A preferred stock dividends                 $ (4,776,260)            
Stock issued due to internalized transaction           4,245,112           4,245,112 0 4,245,112 0
Common Stock, Internalization                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Stock issued due to internalized transaction           7,096,153           7,096,153 0 7,096,153 0
Class B Common Stock, Internalization                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Stock issued due to internalized transaction           $ 3,288,890           $ 3,288,890 $ 0 $ 3,288,890 $ 0
Common Class B                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Beginning balance (in shares) 683,761 683,761 683,761 683,761 683,761       683,761   683,761   683,761    
Ending balance (in shares) 683,761 683,761 683,761 683,761 683,761 683,761     683,761   683,761 683,761 683,761 683,761  
Series A Cumulative Redeemable Preferred Stock                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Beginning balance $ 129,525,675 $ 129,525,675 $ 129,525,675 $ 129,525,675         $ 129,525,675   $ 129,525,675   $ 129,525,675    
Ending balance   $ 129,525,675 $ 129,525,675 $ 129,525,675 $ 129,525,675       $ 129,525,675   $ 129,525,675     $ 129,525,675  
Common Stock                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Beginning balance (in shares)   15,060,857 14,960,628 14,893,184 14,866,799 13,673,326 13,651,521 13,651,521 14,893,184 13,651,521 14,893,184 13,651,521 14,893,184 13,651,521 13,638,916
Beginning balance   $ 15,060 $ 14,960 $ 14,893 $ 14,866 $ 13,673 $ 13,652 $ 13,652 $ 14,893 $ 13,652 $ 14,893 $ 13,652 $ 14,893 $ 13,652 $ 13,639
Reinvestment of dividends paid to common stockholders (in shares)     69,312 67,444   36,228 21,805   136,756       279,957 84,418  
Reinvestment of dividends paid to common stockholders     $ 69 $ 67   $ 36 $ 21   $ 136       $ 280 $ 84  
Common stock issued under director's compensation plan           $ 3               $ 3  
Common stock issued under director's compensation plan (in shares)     30,917     3,399     30,917       80,817 3,399  
Stock-based compensation     $ 31           $ 31       $ 81    
Ending balance (in shares) 15,253,958   15,060,857 14,960,628 14,893,184 14,866,799 13,673,326 13,651,521 15,060,857 13,673,326   14,866,799 15,253,958 14,893,184 13,651,521
Ending balance $ 15,254   $ 15,060 $ 14,960 $ 14,893 $ 14,866 $ 13,673 $ 13,652 $ 15,060 $ 13,673   $ 14,866 $ 15,254 $ 14,893 $ 13,652
Common Stock | Common Stock, Internalization                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Stock issued due to internalized transaction           $ 1,154               $ 1,154  
Stock issued, internalization transaction (in shares)           1,153,846               1,153,846  
Common Stock                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Beginning balance (in shares) 15,176,911 15,060,857   14,893,184         14,893,184   14,893,184   14,893,184    
Beginning balance $ 15,177 $ 15,060   $ 14,893         $ 14,893   $ 14,893   $ 14,893    
Reinvestment of dividends paid to common stockholders (in shares)   84,606                 221,362        
Reinvestment of dividends paid to common stockholders   $ 85                 $ 221        
Common stock issued under director's compensation plan (in shares)   31,448                 62,365        
Stock-based compensation   $ 32                 $ 63        
Ending balance (in shares)   15,176,911 15,060,857   14,893,184       15,060,857   15,176,911     14,893,184  
Ending balance   $ 15,177 $ 15,060   $ 14,893       $ 15,060   $ 15,177     $ 14,893  
Common Stock | Class B Common Stock, Internalization                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Stock issued due to internalized transaction           $ 684               $ 684  
Stock issued, internalization transaction (in shares)           683,761               683,761  
Common Stock | Common Class B                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Beginning balance (in shares) 683,761 683,761 683,761 683,761 683,761 0 0 0 683,761 0 683,761 0 683,761 0 0
Beginning balance $ 684 $ 684 $ 684 $ 684 $ 684 $ 0 $ 0 $ 0 $ 684 $ 0 $ 684 $ 0 $ 684 $ 0 $ 0
Ending balance (in shares) 683,761 683,761 683,761 683,761 683,761 683,761 0 0 683,761 0 683,761 683,761 683,761 683,761 0
Ending balance $ 684 $ 684 $ 684 $ 684 $ 684 $ 684 $ 0 $ 0 $ 684 $ 0 $ 684 $ 684 $ 684 $ 684 $ 0
Preferred Stock                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Beginning balance 129,525,675 129,525,675   129,525,675 129,525,675 125,270,350 125,270,350 125,270,350 129,525,675 125,270,350 129,525,675 125,270,350 129,525,675 125,270,350 125,493,175
Ending balance 129,525,675 129,525,675 129,525,675   129,525,675 129,525,675 125,270,350 125,270,350 129,525,675 125,270,350 129,525,675 129,525,675 129,525,675 129,525,675 125,270,350
Preferred Stock | Series A, Internalization                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Stock issued due to internalized transaction           4,255,325               4,255,325  
Additional Paid-in Capital                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Beginning balance 329,796,049 332,588,181 335,376,932 338,302,735 341,331,070 333,890,657 336,750,132 339,742,380 338,302,735 339,742,380 338,302,735 339,742,380 338,302,735 339,742,380 360,844,497
Series A preferred stock dividends   (2,388,130) (2,388,130) (2,388,130)   (2,388,130) (2,309,672) (2,309,672)     (7,164,390)   (9,552,519) (9,395,604) (9,242,797)
Common Stock dividends   (753,043) (748,031) (744,659)     (682,576) (682,576)     (2,245,733)        
Common Stock dividends           (741,530) (682,576) (682,576) (1,492,690)       (3,004,579) (2,850,026) (12,286,368)
Reinvestment of dividends paid to common stockholders   197,895 196,082 206,986   174,583 132,774   403,068   600,963   803,643 410,496  
Common stock issued under director's compensation plan           22,497               22,497  
Common Stock, accrued dividend equivalent   (34,145)                 (34,145)   (67,431)    
Stock-based compensation   185,291 151,328           151,328   336,619   534,724    
Ending balance 327,016,573 329,796,049 332,588,181 335,376,932 338,302,735 341,331,070 333,890,657 336,750,132 332,588,181 333,890,657 329,796,049 341,331,070 327,016,573 338,302,735 339,742,380
Additional Paid-in Capital | Series A, Internalization                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Series A preferred stock dividends                 (4,776,260)            
Stock issued due to internalized transaction           (10,213)               (10,213)  
Additional Paid-in Capital | Common Stock, Internalization                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Stock issued due to internalized transaction           7,094,999               7,094,999  
Additional Paid-in Capital | Class B Common Stock, Internalization                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Stock issued due to internalized transaction           3,288,206               3,288,206  
Retained Deficit                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Beginning balance (332,423,037) (316,112,121) (317,473,035) (321,028,580) (320,030,693) (324,904,359) (326,320,818) (315,626,555) (321,028,580) (315,626,555) (321,028,580) (315,626,555) (321,028,580) (315,626,555) (9,611,872)
Net income (loss)   (16,310,916) 1,360,914 3,555,545   4,873,667 1,416,458 (10,694,263) 4,916,459   (11,394,457)   (12,756,517) (5,402,025) (306,067,579)
Ending balance (333,785,097) (332,423,037) (316,112,121) (317,473,035) (321,028,580) (320,030,693) (324,904,359) (326,320,818) (316,112,121) (324,904,359) (332,423,037) (320,030,693) (333,785,097) (321,028,580) (315,626,555)
Non-Controlling Interest                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Beginning balance 116,863,817 116,816,116 116,816,116 116,816,116 116,816,116 116,611,762 115,323,036 0 116,816,116 0 116,816,116 0 116,816,116 0 0
Net income (loss)   809,212 809,212 809,212   1,046,304 1,010,951   1,618,424   2,427,636   3,236,848 2,866,467  
Equity attributable to non-controlling interest           204,353 1,288,726 115,323,036           116,816,115  
Crimson cash distribution on A-1 Units   (809,212) (809,212) (809,212)   (841,950) (604,951)   (1,618,424)   (2,427,636)   (3,236,848) (2,256,113)  
Crimson Class A-2 Units dividends payment in kind           (204,353) (406,000)             (610,353)  
Stock-based compensation   47,701                 47,701   77,312    
Ending balance 116,893,428 116,863,817 116,816,116 116,816,116 116,816,116 116,816,116 116,611,762 115,323,036 116,816,116 116,611,762 116,863,817 116,816,116 116,893,428 116,816,116 0
As Previously Reported                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Beginning balance 243,778,365 262,833,595 264,261,332 263,631,523 267,657,718 250,882,083 251,036,352 149,399,827 263,631,523 149,399,827 263,631,523 149,399,827 263,631,523 149,399,827  
Net income (loss)   (15,501,704) 2,170,126 4,364,757   5,919,971 2,427,409 (10,694,263) 6,534,883 (8,266,854) (8,966,821) (2,346,883)   (2,535,558)  
Non-controlling interest   124,193,250 124,353,713 124,196,254 122,945,172 121,534,724 119,220,989 116,928,344 124,353,713 119,220,989 124,193,250 121,534,724   122,945,172  
Series A preferred stock dividends   (2,388,130) (2,388,130) (2,388,130)   (2,388,130) (2,309,672) (2,309,672)     (7,164,390)     (9,395,604)  
Non-controlling interest income allocation   (601,048) (966,671) (2,060,294)   (3,155,685) (2,014,870) (1,605,308) (3,026,965) (3,620,178) (3,628,013) (6,775,863)   (8,995,523)  
Common Stock dividends   (753,043) (748,031) (744,659)     (682,576) (682,576)     (2,245,733)        
Equity attributable to non-controlling interest           204,353 1,288,726 115,323,036           116,816,115  
Common Stock dividends           (741,530) (682,576) (682,576) (1,492,690)         (2,850,026)  
Reinvestment of dividends paid to common stockholders   197,980 196,151 207,053   174,619 132,795   403,204   601,184     410,580  
Common stock issued under director's compensation plan           22,500               22,500  
Common Stock, accrued dividend equivalent   (34,145)                 (34,145)        
Crimson cash distribution on A-1 Units   (809,212) (809,212) (809,212)   (841,950) (604,951)   (1,618,424)   (2,427,636)     (2,256,113)  
Crimson Class A-2 Units dividends payment in kind           (204,353) (406,000)     (406,000)   (610,353)   (610,353)  
Stock-based compensation   233,024 151,359           151,359   384,383        
Ending balance   243,778,365 262,833,595 264,261,332 263,631,523 267,657,718 $ 250,882,083 $ 251,036,352 262,833,595 $ 250,882,083 243,778,365 267,657,718   263,631,523 $ 149,399,827
As Previously Reported | Series A, Internalization                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Series A preferred stock dividends                 (4,776,260)            
Stock issued due to internalized transaction           4,245,112           4,245,112   4,245,112  
As Previously Reported | Common Stock, Internalization                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Stock issued due to internalized transaction           7,096,153           7,096,153   7,096,153  
As Previously Reported | Class B Common Stock, Internalization                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Stock issued due to internalized transaction           $ 3,288,890           $ 3,288,890   3,288,890  
As Previously Reported | Series A Cumulative Redeemable Preferred Stock                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Beginning balance $ 129,525,675 129,525,675 129,525,675 129,525,675         129,525,675   129,525,675   $ 129,525,675    
Ending balance   $ 129,525,675 $ 129,525,675 $ 129,525,675 $ 129,525,675       $ 129,525,675   $ 129,525,675     $ 129,525,675  
As Previously Reported | Common Stock                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Beginning balance (in shares)   15,060,857 14,960,628 14,893,184 14,866,799 13,673,326 13,651,521 13,651,521 14,893,184 13,651,521 14,893,184 13,651,521 14,893,184 13,651,521  
Beginning balance   $ 15,060 $ 14,960 $ 14,893 $ 14,866 $ 13,673 $ 13,652 $ 13,652 $ 14,893 $ 13,652 $ 14,893 $ 13,652 $ 14,893 $ 13,652  
Reinvestment of dividends paid to common stockholders (in shares)     69,312 67,444   36,228 21,805   136,756         84,418  
Reinvestment of dividends paid to common stockholders     $ 69 $ 67   $ 36 $ 21   $ 136         $ 84  
Common stock issued under director's compensation plan           $ 3               $ 3  
Common stock issued under director's compensation plan (in shares)     30,917     3,399     30,917         3,399  
Stock-based compensation     $ 31           $ 31            
Ending balance (in shares)     15,060,857 14,960,628 14,893,184 14,866,799 13,673,326 13,651,521 15,060,857 13,673,326   14,866,799   14,893,184 13,651,521
Ending balance     $ 15,060 $ 14,960 $ 14,893 $ 14,866 $ 13,673 $ 13,652 $ 15,060 $ 13,673   $ 14,866   $ 14,893 $ 13,652
As Previously Reported | Common Stock | Common Stock, Internalization                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Stock issued due to internalized transaction           $ 1,154               $ 1,154  
Stock issued, internalization transaction (in shares)           1,153,846               1,153,846  
As Previously Reported | Common Stock                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Beginning balance (in shares) 15,176,911 15,060,857   14,893,184         14,893,184   14,893,184   14,893,184    
Beginning balance $ 15,177 $ 15,060   $ 14,893         $ 14,893   $ 14,893   $ 14,893    
Reinvestment of dividends paid to common stockholders (in shares)   84,606                 221,362        
Reinvestment of dividends paid to common stockholders   $ 85                 $ 221        
Common stock issued under director's compensation plan (in shares)   31,448                 62,365        
Stock-based compensation   $ 32                 $ 63        
Ending balance (in shares)   15,176,911 15,060,857   14,893,184       15,060,857   15,176,911     14,893,184  
Ending balance   $ 15,177 $ 15,060   $ 14,893       $ 15,060   $ 15,177     $ 14,893  
As Previously Reported | Common Stock | Class B Common Stock, Internalization                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Stock issued due to internalized transaction           $ 684               $ 684  
Stock issued, internalization transaction (in shares)           683,761               683,761  
As Previously Reported | Common Stock | Common Class B                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Beginning balance (in shares) 683,761 683,761 683,761 683,761 683,761 0 0 0 683,761 0 683,761 0 683,761 0  
Beginning balance $ 684 $ 684 $ 684 $ 684 $ 684 $ 0 $ 0 $ 0 $ 684 $ 0 $ 684 $ 0 $ 684 $ 0  
Ending balance (in shares)   683,761 683,761 683,761 683,761 683,761 0 0 683,761 0 683,761 683,761   683,761 0
Ending balance   $ 684 $ 684 $ 684 $ 684 $ 684 $ 0 $ 0 $ 684 $ 0 $ 684 $ 684   $ 684 $ 0
As Previously Reported | Preferred Stock                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Beginning balance 129,525,675 129,525,675   129,525,675 129,525,675 125,270,350 125,270,350 125,270,350 129,525,675 125,270,350 129,525,675 125,270,350 129,525,675 125,270,350  
Ending balance   129,525,675 129,525,675   129,525,675 129,525,675 125,270,350 125,270,350 129,525,675 125,270,350 129,525,675 129,525,675   129,525,675 125,270,350
As Previously Reported | Preferred Stock | Series A, Internalization                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Stock issued due to internalized transaction           4,255,325               4,255,325  
As Previously Reported | Additional Paid-in Capital                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Beginning balance 329,796,049 332,588,181 335,376,932 338,302,735 341,331,070 333,890,657 336,750,132 339,742,380 338,302,735 339,742,380 338,302,735 339,742,380 338,302,735 339,742,380  
Series A preferred stock dividends   (2,388,130) (2,388,130) (2,388,130)   (2,388,130) (2,309,672) (2,309,672)     (7,164,390)     (9,395,604)  
Common Stock dividends   (753,043) (748,031) (744,659)     (682,576) (682,576)     (2,245,733)        
Common Stock dividends           (741,530) (682,576) (682,576) (1,492,690)         (2,850,026)  
Reinvestment of dividends paid to common stockholders   197,895 196,082 206,986   174,583 132,774   403,068   600,963     410,496  
Common stock issued under director's compensation plan           22,497               22,497  
Common Stock, accrued dividend equivalent   (34,145)                 (34,145)        
Stock-based compensation   185,291 151,328           151,328   336,619        
Ending balance   329,796,049 332,588,181 335,376,932 338,302,735 341,331,070 333,890,657 336,750,132 332,588,181 333,890,657 329,796,049 341,331,070   338,302,735 339,742,380
As Previously Reported | Additional Paid-in Capital | Series A, Internalization                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Series A preferred stock dividends                 (4,776,260)            
Stock issued due to internalized transaction           (10,213)               (10,213)  
As Previously Reported | Additional Paid-in Capital | Common Stock, Internalization                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Stock issued due to internalized transaction           7,094,999               7,094,999  
As Previously Reported | Additional Paid-in Capital | Class B Common Stock, Internalization                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Stock issued due to internalized transaction           3,288,206               3,288,206  
As Previously Reported | Retained Deficit                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Beginning balance (339,752,470) (323,649,718) (324,853,173) (327,157,636) (324,749,302) (327,513,587) (327,926,126) (315,626,555) (327,157,636) (315,626,555) (327,157,636) (315,626,555) (327,157,636) (315,626,555)  
Net income (loss)   (16,102,752) 1,203,455 2,304,463   2,764,286 412,539 (12,299,571) 3,507,918   (12,594,834)     (11,531,081)  
Ending balance   (339,752,470) (323,649,718) (324,853,173) (327,157,636) (324,749,302) (327,513,587) (327,926,126) (323,649,718) (327,513,587) (339,752,470) (324,749,302)   (327,157,636) (315,626,555)
As Previously Reported | Non-Controlling Interest                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Beginning balance 124,193,250 124,353,713 124,196,254 122,945,172 121,534,724 119,220,989 116,928,344 0 122,945,172 0 122,945,172 0 122,945,172 0  
Net income (loss)   601,048 966,671 2,060,294   3,155,685 2,014,870 1,605,308 3,026,965   3,628,013     8,995,523  
Equity attributable to non-controlling interest           204,353 1,288,726 115,323,036           116,816,115  
Crimson cash distribution on A-1 Units   (809,212) (809,212) (809,212)   (841,950) (604,951)   (1,618,424)   (2,427,636)     (2,256,113)  
Crimson Class A-2 Units dividends payment in kind           (204,353) (406,000)             (610,353)  
Stock-based compensation   47,701                 47,701        
Ending balance   124,193,250 124,353,713 124,196,254 122,945,172 121,534,724 119,220,989 116,928,344 124,353,713 119,220,989 124,193,250 121,534,724   122,945,172 $ 0
Effect of Restatement                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Beginning balance 0 0 0 0 0 0 0   0   0   0    
Net income (loss)   0 0 0   0 0 0 0 0 0 0   0  
Non-controlling interest   (7,329,433) (7,537,597) (7,380,138) (6,129,056) (4,718,608) (2,609,227) (1,605,308) (7,537,597) (2,609,227) (7,329,433) (4,718,608)   (6,129,056)  
Series A preferred stock dividends               0              
Non-controlling interest income allocation   (208,164) 157,459 1,251,082   2,109,381 1,003,919 1,605,308 1,408,541 2,609,227 1,200,377 4,718,608   6,129,056  
Common Stock dividends               0              
Equity attributable to non-controlling interest               0              
Crimson Class A-2 Units dividends payment in kind                   0   0   0  
Ending balance 0 0 0 0 $ 0 $ 0 $ 0 $ 0 0 $ 0 0 0 0 0  
Adjustments to 2021 Net Income (loss)   0   0             0        
Adjustments to Q1 - Q2 2022 Net Income (loss)   0                          
Effect of Restatement | Series A, Internalization                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Stock issued due to internalized transaction                       0   0  
Effect of Restatement | Common Stock, Internalization                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Stock issued due to internalized transaction                       0   0  
Effect of Restatement | Class B Common Stock, Internalization                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Stock issued due to internalized transaction                       $ 0   $ 0  
Effect of Restatement | Series A Cumulative Redeemable Preferred Stock                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Beginning balance 0 0 0                        
Ending balance $ 0 $ 0 $ 0 $ 0         $ 0   $ 0   $ 0    
Effect of Restatement | Common Stock                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Beginning balance (in shares)   0 0 0 0 0 0   0   0   0    
Beginning balance   $ 0 $ 0 $ 0 $ 0 $ 0 $ 0   $ 0   $ 0   $ 0    
Ending balance (in shares) 0   0 0 0 0 0 0 0 0   0 0 0  
Ending balance $ 0   $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0   $ 0 $ 0 $ 0  
Effect of Restatement | Common Stock                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Beginning balance (in shares) 0                            
Beginning balance $ 0                            
Ending balance (in shares)   0                 0        
Ending balance   $ 0                 $ 0        
Effect of Restatement | Common Stock | Common Class B                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Beginning balance (in shares) 0 0 0 0 0 0 0   0   0   0    
Beginning balance $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0   $ 0   $ 0   $ 0    
Ending balance (in shares) 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
Ending balance $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0  
Effect of Restatement | Preferred Stock                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Beginning balance 0     0 0 0 0   0   0   0    
Ending balance   0     0 0 0 0   0 0 0   0  
Effect of Restatement | Additional Paid-in Capital                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Beginning balance 0 0 0 0 0 0 0   0   0   0    
Ending balance 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
Effect of Restatement | Retained Deficit                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Beginning balance 7,329,433 7,537,597 7,380,138 6,129,056 4,718,608 2,609,227 1,605,308   6,129,056   6,129,056   6,129,056    
Net income (loss)   (208,164) 157,459 1,251,082   2,109,381 1,003,919 1,605,308 1,408,541   1,200,377     6,129,056  
Ending balance 7,380,138 7,329,433 7,537,597 7,380,138 6,129,056 4,718,608 2,609,227 1,605,308 7,537,597 2,609,227 7,329,433 4,718,608 7,380,138 6,129,056  
Adjustments to 2021 Net Income (loss)   6,129,056   6,129,056         6,129,056   6,129,056        
Adjustments to Q1 - Q2 2022 Net Income (loss)   (1,408,541)                          
Effect of Restatement | Non-Controlling Interest                              
Error Corrections and Prior Period Adjustments Restatement [Line Items]                              
Beginning balance (7,329,433) (7,537,597) (7,380,138) (6,129,056) (4,718,608) (2,609,227) (1,605,308)   (6,129,056)   (6,129,056)   (6,129,056)    
Net income (loss)   208,164 (157,459) (1,251,082)   (2,109,381) (1,003,919) (1,605,308) (1,408,541)   (1,200,377)     (6,129,056)  
Ending balance $ (7,380,138) (7,329,433) $ (7,537,597) (7,380,138) $ (6,129,056) $ (4,718,608) $ (2,609,227) $ (1,605,308) (7,537,597) $ (2,609,227) (7,329,433) $ (4,718,608) $ (7,380,138) $ (6,129,056)  
Adjustments to 2021 Net Income (loss)   (6,129,056)   $ (6,129,056)         $ (6,129,056)   $ (6,129,056)        
Adjustments to Q1 - Q2 2022 Net Income (loss)   $ 1,408,541